MNK1 Inhibitor CGP57380 Overcomes mTOR Inhibitor-Induced Activation of eIF4E: The Mechanism of Synergic Killing of Human T-All Cells

Acta Pharmacologica Sinica - United Kingdom
doi 10.1038/s41401-018-0161-0
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Apoptosis and Antitumor Effects Induced by the Combination of an mTOR Inhibitor and an Autophagy Inhibitor in Human Osteosarcoma MG63 Cells

International Journal of Oncology
Cancer ResearchOncology
2015English

Control of the MYC-eIF4E Axis Plus mTOR Inhibitor Treatment in Small Cell Lung Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2015English

MEK Inhibitor PD-0325901 Overcomes Resistance to PI3K/mTOR Inhibitor PF-5212384 and Potentiates Antitumor Effects in Human Head and Neck Squamous Cell Carcinoma

Clinical Cancer Research
Cancer ResearchOncology
2015English

Inhibition of YAP Function Overcomes BRAF Inhibitor Resistance in Melanoma Cancer Stem Cells

Oncotarget
Oncology
2017English

Paradoxical Activation of T Cells via Augmented ERK Signaling Mediated by a RAF Inhibitor

Cancer immunology research
Cancer ResearchImmunology
2013English

Pan-BCL-2 Inhibitor AT-101 Enhances Tumor Cell Killing by EGFR Targeted T Cells

PLoS ONE
Multidisciplinary
2012English

The Hsp90 Inhibitor Geldanamycin Abrogates Colocalization of eIF4E and eIF4E-Transporter Into Stress Granules and Association of eIF4E With eIF4G

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2009English

Inactivation of a Cdk2 Inhibitor During Interleukin 2-Induced Proliferation of Human T Lymphocytes.

Molecular and Cellular Biology
Cell BiologyMolecular Biology
1994English

NVP-BEZ235, a Novel Dual PI3K/mTOR Inhibitor, Enhances the Radiosensitivity of Human Glioma Stem Cells in Vitro

Acta Pharmacologica Sinica
MedicinePharmacology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy